P-031 - CLINICAL PHARMACOLOGY CONSIDERATIONS FOR ANTIBODY-DRUG CONJUGATES (ADCS) IN ONCOLOGY: A REVIEW OF RECENT APPROVALS.

N. Chaphekar¹, A. Parikh²; ¹University of Pittsburgh, Pittsburgh, PA, USA, ²AbbVie Inc., Redwood City, CA, USA.

Presenting Author(s)

Nupur Chaphekar, BS, MS

University of Pittsburgh
Pittsburgh, Pennsylvania, United States